Author

Nadia M Hamdy

Ain Shams UniversityORCID 0000-0003-2105-107XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Haruna Luz Barazorda-CcahuanaiD· 1 shared Luis Daniel Goyzueta-MamaniiD· 1 shared Mahmoud M. Elhefnawi· 1 shared Mayron Antonio Candia-PumaiD· 1 shared Miguel Á. Chávez‐FumagalliiD· 1 shared Nermin M. Mohamed· 1 shared Rania Hassan Mohamed· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 9 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Haruna Luz Barazorda-CcahuanaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintNov 2, 2026

Uncovering the Multifaceted Role of the Kinetochore Scaffold 1 (KNL1) in Hepatocellular Carcinoma: Integrative Bioinformatics Analysis and CRISPR-Cas9 Experimental Study

Nermin M. Mohamed, Rania Hassan Mohamed, Mahmoud M. Elhefnawi, Nadia M Hamdy

This study identifies KNL1 as a key driver of chromosomal instability and immune evasion in HCC through integrative bioinformatics and CRISPR-Cas9 experiments.

DOI 10.64898/2026.10.31.763338

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsbioRxivPreprintFeb 20, 2025

Integrative Computational Analysis of VCX2 in Hepatocellular Carcinoma: From Potential Biomarker Discovery to Therapeutic Targeting with Peruvian Natural Products

Luis Daniel Goyzueta-Mamani, Haruna Luz Barazorda-Ccahuana, Mayron Antonio Candia-Puma…·Miguel Á. Chávez‐Fumagalli

This paper identifies VCX2 as a potential biomarker and therapeutic target in HCC, and identifies Luteolin-5-O-glucoside as a lead compound from Peruvian natural products through computational analysis.

DOI 10.1101/2025.02.20.639333

humanscRNA-seq

𝕏 PostBluesky